These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 15200480)
21. Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes. Droller MJ J Urol; 2001 May; 165(5):1811-2. PubMed ID: 11345951 [No Abstract] [Full Text] [Related]
22. p53 and MDM2 expression in oral squamous cell carcinoma. Matsumura T; Yoshihama Y; Kimura T; Shintani S; Alcalde RE Oncology; 1996; 53(4):308-12. PubMed ID: 8692535 [TBL] [Abstract][Full Text] [Related]
23. p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. Fulop V; Mok SC; Genest DR; Gati I; Doszpod J; Berkowitz RS J Reprod Med; 1998 Feb; 43(2):119-27. PubMed ID: 9513873 [TBL] [Abstract][Full Text] [Related]
24. Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma. Nam TK; Lee JH; Cho SH; Chung IJ; Ahn SJ; Song JY; Yoon MS; Chung WK; Nah BS Cancer Lett; 2008 Feb; 260(1-2):109-17. PubMed ID: 18053639 [TBL] [Abstract][Full Text] [Related]
25. Tumor mapping of regional immunostaining for p21, p53, and mdm2 in locally advanced bladder carcinoma. Jahnson S; Karlsson MG Cancer; 2000 Aug; 89(3):619-29. PubMed ID: 10931462 [TBL] [Abstract][Full Text] [Related]
26. RT-PCR amplification of RNA extracted from formalin-fixed, paraffin-embedded oral cancer sections: analysis of p53 pathway. Tachibana M; Shinagawa Y; Kawamata H; Omotehara F; Horiuchi H; Ohkura Y; Kubota K; Imai Y; Fujibayashi T; Fujimori T Anticancer Res; 2003; 23(3C):2891-6. PubMed ID: 12926130 [TBL] [Abstract][Full Text] [Related]
27. Clinical significance and prognostic value of apoptosis related proteins in superficial esophageal squamous cell carcinoma. Matsumoto M; Natsugoe S; Nakashima S; Okumura H; Sakita H; Baba M; Takao S; Aikou T Ann Surg Oncol; 2001 Aug; 8(7):598-604. PubMed ID: 11508622 [TBL] [Abstract][Full Text] [Related]
28. Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis. Güner D; Sturm I; Hemmati P; Hermann S; Hauptmann S; Wurm R; Budach V; Dörken B; Lorenz M; Daniel PT Int J Cancer; 2003 Feb; 103(4):445-54. PubMed ID: 12478659 [TBL] [Abstract][Full Text] [Related]
29. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan. Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524 [TBL] [Abstract][Full Text] [Related]
30. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer. Ralhan R; Sandhya A; Meera M; Bohdan W; Nootan SK Am J Pathol; 2000 Aug; 157(2):587-96. PubMed ID: 10934161 [TBL] [Abstract][Full Text] [Related]
31. Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology. Qi ZL; Huo X; Xu XJ; Zhang B; Du MG; Yang HW; Zheng LK; Li J; Shen ZY Exp Oncol; 2006 Sep; 28(3):235-40. PubMed ID: 17080019 [TBL] [Abstract][Full Text] [Related]
32. [Expression of P21 WAF1/CIP1 in human astrocytomas in correlating with P53, MDM2, and cellular proliferation index]. Xu QZ; Liu F; Lu DH; Yu SZ; Yang H Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):341-5. PubMed ID: 12940073 [TBL] [Abstract][Full Text] [Related]
33. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications. Agarwal S; Mathur M; Srivastava A; Ralhan R Oral Oncol; 1999 Mar; 35(2):209-16. PubMed ID: 10435158 [TBL] [Abstract][Full Text] [Related]
34. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma. Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040 [TBL] [Abstract][Full Text] [Related]
35. Distribution and prognostic significance of cell cycle proteins in squamous carcinoma of the larynx, hypopharynx and adjacent epithelial hyperplastic lesions. Volavsek M; Bracko M; Gale N J Laryngol Otol; 2003 Apr; 117(4):286-93. PubMed ID: 12816218 [TBL] [Abstract][Full Text] [Related]
36. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796 [TBL] [Abstract][Full Text] [Related]
37. Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications. Antonescu CR; Leung DH; Dudas M; Ladanyi M; Brennan M; Woodruff JM; Cordon-Cardo C Am J Pathol; 2000 Mar; 156(3):977-83. PubMed ID: 10702413 [TBL] [Abstract][Full Text] [Related]
38. Analysis of p16(INK4A) expression of oral squamous cell carcinomas in Taiwan: prognostic correlation without relevance to betel quid consumption. Chen YW; Kao SY; Yang MH J Surg Oncol; 2012 Aug; 106(2):149-54. PubMed ID: 22354873 [TBL] [Abstract][Full Text] [Related]
39. TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus. Skomedal H; Kristensen GB; Nesland JM; Børresen-Dale AL; Tropé C; Holm R J Pathol; 1999 Apr; 187(5):556-62. PubMed ID: 10398121 [TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas. Skomedal H; Kristensen GB; Lie AK; Holm R Gynecol Oncol; 1999 May; 73(2):223-8. PubMed ID: 10329038 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]